Medtronic plc announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system… read more.
NICE (UK): Delgocitinib can be used, within its marketing authorisation, as an option to treat moderate to severe chronic hand eczema in adults when topical corticosteroids have not… read more.
Pelthos Therapeutics Inc. announced it has acquired the U.S. marketing rights to Xepi (ozenoxacin) Cream, 1%, from Biofrontera Inc. and Ferrer Internacional S.A. (the Xepi is a non-fluorinated… read more.
Takeda announced the completion of the 7-year pivotal Phase III Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated])… read more.
At ObesityWeek taking place in Atlanta, US, Novo Nordisk presented new findings from the STEP UP phase IIIb trial. It showed that, in addition to losing an average… read more.
Amneal Pharmaceuticals, Inc. announced the U.S. commercial launch of Brekiya (dihydroergotamine mesylate) injection, the first and only ready-to-use dihydroergotamine (DHE) autoinjector approved for the acute treatment of migraine… read more.
Guardant Health Inc announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based screening test demonstrates patient adherence of 95% in screening… read more.
Eisai and Merck & Co., Inc., (known as MSD outside of the United States and Canada) announced results from that Phase III LEAP-012 trial evaluating Lenvima (lenvatinib), the… read more.
Journey Medical Corporation announced that the FDA has approved Emrosi(minocycline hydrochloride extended release capsules, 40 mg), formerly referred to as DFD-29, for the treatment of inflammatory lesions of… read more.
Bavarian Nordic A/S announced the award of a joint procurement contract by the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), enabling the EU, its… read more.
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology Clinical Practice,… read more.
Amneal Pharmaceuticals, Inc. announced that the FDA has tentatively approved the Company’s Abbreviated New Drug Application (ANDA) for beclomethasone dipropionate HFA inhalation aerosol (40 mcg/actuation and 80 mcg/actuation)…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
